Results 11 to 20 of about 37,991 (280)

Eosinophilia and parasitic infestations in patients with chronic obstructive pulmonary disease [PDF]

open access: goldScientific Reports, 2020
Eosinophilia may guide response to inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease (COPD). This study aimed to determine prevalence of eosinophilia and parasitic infestations in these patients.
Narongkorn Saiphoklang, Chanya Chomchoey
doaj   +2 more sources

Eosinophilia Is a Favorable Marker for Pneumonia in Chronic Obstructive Pulmonary Disease [PDF]

open access: diamondTuberculosis and Respiratory Diseases
Background Patients with chronic obstructive pulmonary disease (COPD) expressing eosinophilia experience slightly fewer episodes of community-acquired pneumonia (CAP), than those without eosinophilia.
Kang-Mo Gu   +10 more
doaj   +3 more sources

Clarithromycin and pulmonary infiltration with eosinophilia [PDF]

open access: greenBMJ, 2003
Pulmonary diseases induced by drugs include bronchial asthma, pulmonary infiltration with eosinophilia, diffuse fibrosing alveolitis, vasculitis, and pleural diseases.1–4 Most such diseases recede when the drug is withdrawn, although on rare occasions the pulmonary damage is irreversible and progressive.4 5 We describe a patient with asthma referred to
Angelo Petroianni, Claudio Terzano
openaire   +4 more sources

Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia. [PDF]

open access: yesBMC Pulm Med, 2017
Background Fungi can cause a variety of infectious diseases, including invasive mycosis and non-invasive mycosis, as well as allergic diseases. The different forms of mycosis usually have been described as mutually exclusive, independent entities, with ...
Hirano T   +12 more
europepmc   +2 more sources

Acetaminophen Use: An Unusual Cause of Drug-Induced Pulmonary Eosinophilia. [PDF]

open access: yesCan Respir J, 2016
Pulmonary eosinophilia (PE) can be found in very diverse pathological processes. Several medications have also been associated with this entity. Acetaminophen is a medication commonly used in multiple different drug formulations, many of which are ...
Saint-Pierre MD, Moran-Mendoza O.
europepmc   +2 more sources

Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity. The most common form of pulmonary complication is interstitial pneumonitis which is treated with discontinuation of amiodarone ...
Meor Azraai   +2 more
doaj   +1 more source

Frequency of Eosinophilia among Patients of Chronic Obstructive Pulmonary Disease with Acute Exacerbation

open access: yesJournal of Aziz Fatimah Medical and Dental College, 2021
Objective: To determine the frequency of eosinophilia among patients of chronic obstructive pulmonary disease with acute exacerbation Methodology: This cross-sectional study was carried out at Aziz Fatimah Hospital (AFH), Faisalabad from February 2020 ...
Masood Javed   +5 more
doaj   +1 more source

EOSINOPHILIA AS TRIGGER FACTOR FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLIA IN A PACIENT WITH THROMBOPHILIA [PDF]

open access: yesRomanian Journal of Infectious Diseases, 2017
Introduction. Pulmonary infiltrate and eosinophilia represent a heterogenous group of diseases causes by extrinsic or intrinsic factors. Extrinsic factors represented by medication or infectious agents (parasites, fungi, mycobacteria) may trigger an ...
Marilena Constantin   +3 more
doaj   +1 more source

Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report. [PDF]

open access: yesJ Med Case Rep
Background Drug rash with eosinophilia and systemic symptoms syndrome is a severe T-cell-mediated adverse drug reaction characterized by a skin rash, fever, hematologic abnormalities, and internal organ involvement following prolonged exposure to a ...
Kim S, Chen K, Stull W.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy